The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.1 - Manufacture of basic pharmaceutical products
100 jobs Number of planned job losses
Announcement Date
2 December 2015
Employment effect (start)
1 January 2016
Foreseen end date
31 December 2016
Description
German pharmaceutical company Ratiopharm will cut 100 jobs out of 2,500 in Ulm over the course of 2016 in an effort to save costs and ensure competitiveness. Teva Deutschland, Ratiopharm's parent company, aims to draw on voluntary redundancies and internal transfers as much as possible in order to minimise the number of compulsory redundancies. Alongside job cuts, Ratiopharm is also considering outsourcing certain processes and tasks which are not directly related to its production.
Rationpharm is a German pharmaceutical company with headquarters in Ulm. The company was taken over by Teva in October 2010. Currently around 3,100 employees are working for Rationpharm in Germany including 2,500 employees at its headquarter in Ulm.
Sources
2 December 2015: Augsburger Allgemeine Online
22 November 2015: Frankfurter Allgemeine Zeitung Online
23 November 2015: Südwest Presse Online
Citation
Eurofound (2015), Ratiopharm, Internal restructuring in Germany, factsheet number 85656, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/85656.